GL1X · GenesisL1 explorer

Research workbench

H-pgds complexed with inhibitor 1Y

Analyse H-pgds complexed with inhibitor 1Y in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6W8H
Type
protein
Length
397 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hematopoietic prostaglandin D synthase
EC
5.3.99.2, 2.5.1.18
UniProt
O60760
Ligands
GSH, TJG
Pockets
2 · best druggability 0.79

Structure

x-ray diffraction · 2 distinct chains · 58% helix, 10% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHematopoietic prostaglandin D synthase (EC 5.3.99.2, 2.5.1.18)protein19857% helix, 10% strandO60760
CHematopoietic prostaglandin D synthase (EC 5.3.99.2, 2.5.1.18)protein19958% helix, 10% strandO60760

Ligands and binding sites

  • GSH · Glutathione · ligand · 2 copies · chains A, C
  • TJG · 7-cyclopropyl-N-[trans-4-(2-hydroxypropan-2-yl) cyclohexyl]-1,8-naphthyridine-3-carboxamide · ligand · 2 copies · chains A, C
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110690.790.8083GSH, TJG
2870.480.8224empty

Interfaces

1 interface between chains.

  • A–C · 1408 Ų buried · 13 hydrogen bonds · protein-protein

Compared structures

  • 6W8H · H-PGDS complexed with inhibitor 1Y · the same entry in another collection · chain A against A, TM-score 1.00
  • O60760 · AlphaFold monomer V2.0 prediction for hematopoietic prostaglandin D synthase (O60760) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.